Another attempt to treat primary tic disorders with Cannabis-based medicine is monoacylglycerol lipase (MAGL) inhibition, which is said to prevent the breakdown of endocannabinoids (Pan et al. 2009). This evidence concerns the gene MGLL and tic disorder.